Tomim Dabna H, Pontarolla Felipe M, Bertolini Jessica F, Arase Mauricio, Tobaldini Glaucia, Lima Marcelo M S, Fischer Luana
Department of Physiology, Division of Biological Sciences, Federal University of Parana, Curitiba, Parana, Brazil.
Mol Neurobiol. 2016 Apr;53(3):1706-1717. doi: 10.1007/s12035-014-9059-0. Epub 2015 Feb 24.
The mechanisms underlying the pronociceptive effect of paradoxical sleep deprivation (PSD) are not known. In this study, we asked whether PSD increases tonic nociception in the formalin test, decreases the antinociceptive effect of morphine administered into the periaqueductal gray matter (PAG), and disrupts endogenous descending pain modulation. PSD for either 24 or 48 h significantly increased formalin-induced nociception and decreased mechanical nociceptive paw withdrawal threshold. The maximal antinociceptive effect induced by morphine (0.9-9 nmol, intra-PAG) was significantly decreased by PSD. The administration of a low dose of the GABAA receptor antagonist, bicuculline (30-300 pmol, intra-PAG), decreased nociception in control rats, but not in paradoxical-sleep-deprived ones. Furthermore, the administration of the cholecystokinin (CCK) 2 receptor antagonist, YM022 (0.5-2 pmol) in the rostral ventral medulla (RVM), decreased nociception in paradoxical-sleep-deprived rats but not in control ones. While a dose of the CCK 2 receptor agonist, CCK-8 (8-24 pmol intra-RVM), increased nociception in control rats, but not in paradoxical-sleep-deprived ones. In addition, the injection of lidocaine (QX-314, 2%, intra-RVM) decreased nociception in sleep-deprived rats, but not in control rats, while the lesion of the dorsolateral funiculus prevented the pronociceptive effect of PSD. Finally, PSD significantly increased c-Fos expression in the RVM. Therefore, PSD increases pain independently of its duration or of the characteristic of the nociceptive stimulus and decreases morphine analgesia at the PAG. PSD appears to increase pain by decreasing descending pain inhibitory activity and by increasing descending pain facilitatory activity.
异相睡眠剥夺(PSD)产生促伤害性作用的潜在机制尚不清楚。在本研究中,我们探讨了PSD是否会增加福尔马林试验中的紧张性伤害感受,降低注入中脑导水管周围灰质(PAG)的吗啡的抗伤害性作用,以及是否会破坏内源性下行疼痛调制。24小时或48小时的PSD显著增加了福尔马林诱导的伤害感受,并降低了机械性伤害感受的爪退缩阈值。PSD显著降低了吗啡(0.9 - 9纳摩尔,脑导水管周围灰质内注射)诱导的最大抗伤害性作用。低剂量的GABAA受体拮抗剂荷包牡丹碱(30 - 300皮摩尔,脑导水管周围灰质内注射)可降低对照大鼠的伤害感受,但对异相睡眠剥夺大鼠无效。此外,在延髓头端腹内侧(RVM)注射胆囊收缩素(CCK)2受体拮抗剂YM022(0.5 - 2皮摩尔)可降低异相睡眠剥夺大鼠的伤害感受,但对对照大鼠无效。而给予CCK 2受体激动剂CCK - 8(8 - 24皮摩尔,延髓头端腹内侧内注射)可增加对照大鼠的伤害感受,但对异相睡眠剥夺大鼠无效。此外,注射利多卡因(QX - 314,2%,延髓头端腹内侧内注射)可降低睡眠剥夺大鼠的伤害感受,但对对照大鼠无效,而背外侧索损伤可阻止PSD的促伤害性作用。最后,PSD显著增加了延髓头端腹内侧的c - Fos表达。因此,PSD增加疼痛与其持续时间或伤害性刺激的特征无关,并降低了PAG处的吗啡镇痛作用。PSD似乎通过降低下行性疼痛抑制活动和增加下行性疼痛易化活动来增加疼痛。